Raveum Appoints Global Biopharma Executive Chintan Ghedia to Board of Directors

Published: January 08, 2026 | Category: real estate news
Raveum Appoints Global Biopharma Executive Chintan Ghedia to Board of Directors

Austin (Texas) [USA], January 7: Raveum, a global platform expanding access to institutional-grade U.S. real estate, today announced the appointment of Chintan Ghedia to its Board of Directors. His addition marks a strategic step in Raveum’s next phase of growth as the company scales its compliance-first model for global investors seeking exposure to U.S. real estate assets.

“Chintan understands that in the future of finance, regulatory integrity is the ultimate accelerator,” said Kabir Israni, CEO at Raveum. “As we bridge the gap for retail and emerging-market investors, his experience allows us to turn complex compliance into a competitive advantage—delivering a transparent, tech-enabled experience that opens the world’s markets to everyone.”

As a board member, Ghedia will advise on go-to-market strategy, strategic partnerships, and ensuring that Raveum remains nimble and disciplined as it broadens its footprint.

“Growing up in India, I saw firsthand how limited access to financial opportunity can shape, and sometimes restrict, an individual’s path to growth and prosperity,” said Ghedia. “That’s why Raveum’s mission deeply resonates with me – it is democratizing access to global real estate while building trust and advancing financial literacy.”

Chintan Ghedia is a results-driven pharmaceutical executive with over 20 years of experience commercializing life-changing cancer medicines across the world. Ghedia is recognized for complex launches, managed multi-market P&Ls, and elevating high-performing senior-level teams to launch and scale innovative cancer medicines across highly regulated, complex global markets.

With this appointment, Raveum strengthens its leadership as it continues building a globally inclusive, trust-led U.S. real estate investment platform designed for long-term participation and resilience.

About Raveum

Raveum is a global investment platform dedicated to expanding access to U.S. real estate through fractional ownership. Built on principles of transparency and institutional governance, Raveum provides a structured pathway for international investors to participate in high-quality real estate assets, fostering global financial inclusivity.

Stay Updated with GeoSquare WhatsApp Channels

Get the latest real estate news, market insights, auctions, and project updates delivered directly to your WhatsApp. No spam, only high-value alerts.

GeoSquare Real Estate News WhatsApp Channel Preview

Never Miss a Real Estate News Update — Get Daily, High-Value Alerts on WhatsApp!

Frequently Asked Questions

1. What is Raveum's main focus?
Raveum is focused on expanding access to institutional-grade U.S. real estate through fractional ownership, providing a transparent and tech-enabled platform for global investors.
2. Who is Chintan Ghedi
and why was he appointed to Raveum's Board of Directors? A: Chintan Ghedia is a seasoned biopharma executive with over 20 years of experience. He was appointed to Raveum's Board of Directors to advise on go-to-market strategy and ensure regulatory integrity.
3. What is the significance of regulatory integrity in Raveum's business model?
Regulatory integrity is crucial for Raveum as it ensures compliance and trust, which are essential for scaling the company's platform and attracting global investors.
4. How does Raveum plan to democratize access to U.S. real estate?
Raveum aims to democratize access by providing a transparent, tech-enabled platform that allows retail and emerging-market investors to participate in high-quality U.S. real estate assets through fractional ownership.
5. What is Chintan Ghedia's background in the pharmaceutical industry?
Chintan Ghedia has over 20 years of experience in the pharmaceutical industry, specializing in commercializing life-changing cancer medicines and managing multi-market P&Ls.